decane has been researched along with Glioblastoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Assoah, B; Candeias, NR; Kandhavelu, M; Kute, D; Musa, A; Paakkunainen, A; Saravanan, KM; Viswanathan, A; Yli-Harja, O; Zhurina, A | 1 |
1 other study(ies) available for decane and Glioblastoma
| Article | Year |
|---|---|
Decane-1,2-diol derivatives as potential antitumor agents for the treatment of glioblastoma.
Topics: Alkanes; Antineoplastic Agents; Apoptosis; Brain Neoplasms; Caspase 3; Caspase 7; Cell Line, Tumor; Cell Proliferation; Glioblastoma; Humans; Molecular Docking Simulation; Oxidative Stress; Receptors, N-Methyl-D-Aspartate | 2018 |